Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer

NCT02526368 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Localized Prostate Carcinoma

Interventions

DRUG: Hyperpolarized 13C-Pyruvate
DRUG: Hyperpolarized 13C,15N2-urea
PROCEDURE: Magnetic Resonance Spectroscopic Imaging

Sponsor

Ivan de Kouchkovsky, MD

Collaborators

[object Object]
[object Object]
[object Object]